The biodegradable polymer Poly (D,L-lactide-co-glycolic acid) (PLGA) is widely regarded as safe for use in medical applications, seeing common use in the creation of particles used in in vivo studies.

Purdue University researchers are developing and validating patent-pending poly (lactic-co-glycolic acid), or PLGA, nanoparticles modified with adenosine triphosphate, or ATP, to enhance immunotherapy ...

Active pharmaceutical ingredients (APIs), including both small molecules and biologic compounds, are often encapsulated in microspheres and nanoparticles. This encapsulation is utilized for specific ...

A new nanoparticle made from the medical polymer PLGA and the blood protein albumin can carry higher doses of drugs and remain stable longer, offering improved delivery and fewer side effects. For ...

Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy Request A Quote Download ...

Scientists at Xi’an Jiaotong-Liverpool University (XJTLU) and at Nanjing University have combined a widely used medical polymer with a natural blood protein to develop a new nanoparticle drug delivery ...

Researchers are enhancing immunotherapy effects against malignant tumors by developing and validating patent-ending poly (lactic-co-glycolic acid), or PLGA, nanoparticles modified with adenosine ...

A new nanoparticle capable of carrying much higher doses of drugs while staying stable for extended periods could make treatments more effective. A new nanoparticle made from the medical polymer PLGA ...